melanoma-2017-keynote

2 / 5

Volume 2, Issue 3 2017 Journal of Medical Oncology and Therapeutics Dermatologists & Melanoma 2017
August 31-September 01, 2017
Page 47
Notes:
&
2nd Euro-Global Congress on
August 31-September 01, 2017 London, UK
12th Global Dermatologists Congress
Melanoma and Skin Diseases
Hana Zelenkova, J Med Oncl Ther 2017, 2:3
Maximum efficient treatment of haemangiomas in infants
Haemangiomas are benign vascular tumours composed of an increased number of unique endothelial cells that line blood
distinguish between single capillary haemangiomas and haemangiomatosis, defined asmultiple haemangiomas
that may occur anywhere on the skin or mucous membranes. Haemangioma may occur in any location supplied with blood
vessels (skin, internal organs, and bones). Capillary haemangiomas appear on skin or mucous membranes supplied through
capillaries with a very small internal diameter. Haemangiomas affecting internal organs (liver, kidneys, brain, spleen or the
lungs) are usually detected accidentally. The size of haemangioma, especially on the skin, ranges from millimetres to several
centimetres, forming a bright red or bluish-red lesion. Haemangiomas are the most common benign tumours in infants,
appearing in 3% of new-borns, usually affecting the face – the nose, the lips, the eyelids or the genitalia (labia minor, clitoris,
scrotum), and they should be considered urgent conditions requiring an adequate treatment. An extraordinarily elegant
and safe treatment with excellent results, practically without undesired effects is the oral administration of the beta-blocker
propranolol. After the initial examination, the administration requires the cooperation of a dermatologist, a paediatrician, and
a cardiologist. We are going to present the cases of our patients before and after six months of therapy with propranolol with
an excellent effect on various localities on the skin.
Biography
Hana Zelenková has been active in the field of Dermatovenerology since 1973. Since 2000 she has been directing her own Private Clinic of Dermatovenerology. Her
professional orientation is towards: aesthetic dermatology, acne and facial dermatoses, medicinal mycology (nail diseases), wound management, psoriasis, employment
of Ichthyol and carboxytherapy in dermatology. She is the coordinator of many international multicentre trials. She has delivered more than 555 lectures as expert in the
Slovak Republic as well as abroad, 440 scientific publications. She is Co-author of the Dermatocosmetic formulae containing Ichthammol and glycyrrhiziic acid. She is
also the author of the book “Carboxytherapy” (2015) translated into 4 languages. She is regularly invited to deliver lectures at international congresses. She is the Founder
and President of the Slovak Society for Aesthetic and Cosmetic Dermatology (SSEDK), Organizer and President of the traditional international DERMAPARTY congress.
Since 2006, she is elected as the Vice-President European Society of Aesthetic and Cosmetic Dermatology, since 2007 President of the European Society of Aesthetic
and Cosmetic Dermatology.
Hana Zelenkova
Private Clinic of Dermatovenerology, DOST Svidník, Slovakia